A recent study in rodents concluded that TIGIT is the most reliable marker to detect and reverse exhausted Tex in liver cancer [69] and also other studies show the importance of TIGIT as a target for immunotherapy in HCC patients (reviewed in [70]). Here, TIGIT is linked to hepatocellular carcinoma.